$HR

Harbour Investments Inc. Has $1.19 Million Holdings in Healthcare Realty Trust Incorporated $HR

Harbour Investments Inc. increased its stake in Healthcare Realty Trust (NYSE:HR) by 3,394.4% in Q4, buying 68,159 shares to hold 70,167 shares worth $1.189M, per its latest SEC 13F. The article also cites analyst target changes (consensus $20.25) and HR’s Q1 results: $0.41 EPS vs $0.39 expected; revenue $275.28M vs $283.01M.

Original reporting
Published May 30, 2026, 11:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 30, 2026, 11:51 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Harbour Investments Inc. Has $1.19 Million Holdings in Healthcare Realty Trust Incorporated $HR — source image
Decision brief

The 30-second read

$HRBullishLow
01

Why it matters

For traders, the actionable element is the sentiment/positioning signal from institutional accumulation and insider buying; however, without new guidance, contract, or earnings revisions, impact is likely incremental.

02

Market read

Institutional accumulation and insider buying provide a small bullish tilt, but the piece lacks a new fundamental trigger beyond previously reported earnings/guidance and routine dividend/ratings updates.

03

What to watch

The article does not add new operating metrics; the most decision-relevant items (earnings/guidance) are referenced but not updated in this piece.

Relevance 6/10Novelty 4/10Timing: after-hours/next-session positioning read-through from 13F and insider buy

Background

The article summarizes Harbour Investments’ 13F increase in HR, plus other institutional activity, a director share purchase, and recent analyst target/rating changes; it also reiterates the latest quarterly results, FY 2026 EPS guidance, and the most recent dividend.

Company-level read

Ticker impact

$HRBullishMedium confidence
Context

Harbour Investments disclosed a 3,394% stake increase in Healthcare Realty Trust via its latest 13F, alongside an insider buy and recent analyst target moves.

Expected impact

Near-term bias slightly higher, with limited follow-through unless earnings/dividend/guidance details change.

Evidence & confidence

The only fresh, company-specific datapoints here are the 13F position increase and a director’s Form 4 buy; these can influence sentiment but do not directly reset cash-flow expectations like new guidance or a deal.

Market effects

Healthcare REITs may see small sentiment lift if institutional demand is interpreted as confidence in outpatient medical real estate.

No explicit regional catalyst beyond the company’s general US footprint.

Limited; this is US REIT-specific positioning and analyst/ownership signals.

Counterpoint

A large 13F percentage jump can be driven by a small starting base and may not reflect a durable change in fundamentals.

Key entities

  • Healthcare Realty Trust Incorporated

    US healthcare REIT; subject of the 13F stake increase, director insider purchase, and analyst target/rating updates.

  • Harbour Investments Inc.

    Reported a large percentage increase in its HR holdings in the latest 13F filing.

  • Thomas N. Bohjalian

    Director who purchased 10,000 HR shares at an average $18.09 per share (SEC-disclosed transaction).

Related articles

$HRMedAI 8/10

Healthcare Realty Trust (HR) Q2 2026 Earnings Call Transcript

Healthcare Realty Trust (HR) reported Q2 2026 normalized FFO of $0.41/share and same-store cash NOI growth of 5.1% y/y. It raised normalized FFO guidance to $1.62 to $1.66/share and same-store cash NOI growth guidance to 4.3% to 5.0%. GAAP net loss was $0.13/share after $42.7m impairments. HR also discussed $200m JV acquisitions, $83m asset dispositions, and $75m Q2 repurchases.

$HRMed

Healthcare Realty Trust: Q2 Earnings Snapshot

Healthcare Realty Trust (HR) reported Q2 funds from operations of $143.7 million, or 41 cents per share, beating a Zacks-surveyed analyst average of 40 cents. The company posted a Q2 loss of $43.5 million, or 13 cents per share, and revenue of $281.8 million. Full-year FFO guidance is $1.62 to $1.66 per share.

$HRHigh

Healthcare Realty Trust Inc (HR): Results of Operations and Financial Condition

Healthcare Realty Trust Inc (HR) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release HEALTHCARE REALTY REPORTS SECOND QUARTER 2026 RESULTS AND FURTHER INCREASES FULL YEAR 2026 GUIDANCE NASHVILLE, Tennessee, July 30, 2026. Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2026. I n addition, t

$MSFTHigh

Prediction: Microsoft Could Be the Next $5 Trillion Stock

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi